{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:05:25Z","timestamp":1779919525710,"version":"3.53.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jtct.2025.01.893","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:05:44Z","timestamp":1738713944000},"page":"263.e1-263.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Bodyweight and Absolute Lymphocyte Count-Based Dosing of Rabbit Anti-thymocyte Globulin Results in Early CD4+ Immune Reconstitution in Patients with Inborn Errors of Metabolism Undergoing Umbilical Cord Blood Transplantation"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3010-7525","authenticated-orcid":false,"given":"Daniel","family":"Drozdov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Kandil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2730-451X","authenticated-orcid":false,"given":"Susie E.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor V.","family":"Demorest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-8919","authenticated-orcid":false,"given":"Troy C.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish O.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2232-6952","authenticated-orcid":false,"given":"Jaap Jan","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jtct.2025.01.893_bib0001","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/S2352-3026(21)00375-6","article-title":"Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial","volume":"9","author":"Admiraal","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jtct.2025.01.893_bib0002","series-title":"Enric Carreras, eds. The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies","author":"Sureda","year":"2024"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.893_bib0003","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.893_bib0004","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/sctm.17-0069","article-title":"Umbilical cord blood transplantation: challenges and future directions","volume":"6","author":"Ballen","year":"2017","journal-title":"Stem Cells Transl Med"},{"issue":"7","key":"10.1016\/j.jtct.2025.01.893_bib0005","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/cancers12071974","article-title":"Reconstitution of T cell subsets following allogeneic hematopoietic cell transplantation","volume":"12","author":"Dekker","year":"2020","journal-title":"Cancers"},{"issue":"23","key":"10.1016\/j.jtct.2025.01.893_bib0006","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood-2016-06-721936","article-title":"Excellent T-cell reconstitution and survival depend on low ATG exposure after pediatric cord blood transplantation","volume":"128","author":"Admiraal","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.893_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2015.08.028","article-title":"Immune reconstitution after allogeneic hematopoietic cell transplantation in children","volume":"22","author":"de Koning","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.893_bib0008","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.2020007905","article-title":"CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation","volume":"137","author":"de Koning","year":"2021","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2025.01.893_bib0009","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcyt.2023.05.012","article-title":"Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis","volume":"25","author":"Troullioud Lucas","year":"2023","journal-title":"Cytotherapy"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.893_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2007.04.054","article-title":"hematopoietic cell therapy for metabolic disease","volume":"151","author":"Orchard","year":"2007","journal-title":"J. Pediatr"},{"issue":"12","key":"10.1016\/j.jtct.2025.01.893_bib0011","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1182\/blood-2018-11-887240","article-title":"Successful donor engraftment and repair of the blood-brain barrier in cerebral adrenoleukodystrophy","volume":"133","author":"Orchard","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.893_bib0012","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.bbmt.2012.10.026","article-title":"Multi-institutional assessments of transplantation for metabolic disorders","volume":"19","author":"Orchard","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.893_bib0013","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/bjh.13059","article-title":"Transplantation in inborn errors of metabolism: current considerations and future perspectives","volume":"167","author":"Boelens","year":"2014","journal-title":"B. J Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.893_bib0014","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.bbmt.2019.11.014","article-title":"Reduced-toxicity (BuFlu) conditioning is better tolerated but has a higher second transplantation rate compared to myeloablative conditioning (BuCy) in children with inherited metabolic disorders","volume":"26","author":"Gupta","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3853","key":"10.1016\/j.jtct.2025.01.893_bib0015","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1126\/science.162.3853.570","article-title":"Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts","volume":"162","author":"Fratantoni","year":"1968","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.jtct.2025.01.893_bib0016","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin Immunopathol"},{"issue":"2","key":"10.1016\/j.jtct.2025.01.893_bib0017","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbmt.2008.11.022","article-title":"Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation","volume":"15","author":"Bartelink","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"10.1016\/j.jtct.2025.01.893_bib0018","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","article-title":"Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis","volume":"3","author":"Bartelink","year":"2016","journal-title":"Lancet Haematol"},{"issue":"9915","key":"10.1016\/j.jtct.2025.01.893_bib0019","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","article-title":"Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study","volume":"383","author":"G\u00fcng\u00f6r","year":"2014","journal-title":"The Lancet"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.893_bib0020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10875-020-00888-2","article-title":"Experience with a reduced toxicity allogeneic transplant regimen for non-CGD primary immune deficiencies requiring myeloablation","volume":"41","author":"Chandra","year":"2021","journal-title":"J Clin Immunol"},{"issue":"7","key":"10.1016\/j.jtct.2025.01.893_bib0021","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","article-title":"Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond","volume":"21","author":"Mohty","year":"2007","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.893_bib0022","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.893_bib0023","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3324\/haematol.2019.227603","article-title":"Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin","volume":"105","author":"Baron","year":"2020","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.893_bib0024","article-title":"Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults","volume":"2023","author":"Chakupurakal","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtct.2025.01.893_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2024.05.015","article-title":"Model-based antithymocyte globulin in \u03b1\u03b2haplo-hematopoietic stem cell transplantation facilitates engraftment, expedites t cell recovery, and mitigates the risk of acute graft-versus-host disease","author":"Barbarito","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.893_bib0026","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40262-014-0214-6","article-title":"Population pharmacokinetic modeling of thymoglobulin\u00ae in children receiving allogeneic-hematopoietic cell transplantation: towards improved survival through individualized dosing","volume":"54","author":"Admiraal","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jtct.2025.01.893_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.828094","article-title":"Therapeutic drug monitoring of anti-thymocyte globulin in allogeneic stem cell transplantation: proof of concept","volume":"13","author":"Meesters-Ensing","year":"2022","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.jtct.2025.01.893_bib0028","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/S2352-3026(15)00045-9","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.jtct.2025.01.893_bib0029","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","article-title":"Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis","volume":"4","author":"Admiraal","year":"2017","journal-title":"Lancet Haematol"},{"issue":"3","key":"10.1016\/j.jtct.2025.01.893_bib0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbmt.2017.11.020","article-title":"Antithymocyte globulin: steps toward individualized dosing","volume":"24","author":"Admiraal","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.893_bib0031","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbmt.2017.08.029","article-title":"Optimizing antithymocyte globulin dosing for unrelated donor allogeneic hematopoietic cell transplantation based on recipient absolute lymphocyte count","volume":"24","author":"Kennedy","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.01.893_bib0032","unstructured":"Study Details | A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant |. ClinicalTrials.gov. NCT04872595.https:\/\/clinicaltrials.gov\/study\/NCT04872595?cond=ATG&term=PRAISE-IR&rank=1"},{"key":"10.1016\/j.jtct.2025.01.893_bib0033","unstructured":"Study Details | Studying Conditioning Regimen in Pediatric Transplantation - AML, SCRIPT-AML | ClinicalTrials.gov. NCT05477589https:\/\/clinicaltrials.gov\/study\/NCT04872595?cond=ATG&term=PRAISE-IR&rank=1"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.893_bib0034","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1182\/bloodadvances.2019000836","article-title":"Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin","volume":"4","author":"Politikos","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.jtct.2025.01.893_bib0035","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/bloodadvances.2022009038","article-title":"Cord blood transplantation for nonmalignant disorders: early functional immunity and high survival","volume":"7","author":"Martinez","year":"2023","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.jtct.2025.01.893_bib0036","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/s41409-020-01179-5","article-title":"Consensus opinion on immune-mediated cytopenias after hematopoietic cell transplant for inherited metabolic disorders","volume":"56","author":"Gupta","year":"2021","journal-title":"Bone Marrow Transplant"},{"issue":"446","key":"10.1016\/j.jtct.2025.01.893_bib0037","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.jtct.2025.01.893_bib0038","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/blood-2013-05-502385","article-title":"Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome","volume":"123","author":"Lindemans","year":"2014","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725010061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T09:05:48Z","timestamp":1743498348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725010061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2666636725010061"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.01.893","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bodyweight and Absolute Lymphocyte Count-Based Dosing of Rabbit Anti-thymocyte Globulin Results in Early CD4+ Immune Reconstitution in Patients with Inborn Errors of Metabolism Undergoing Umbilical Cord Blood Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.01.893","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}